DR. CLINT DANIEL KINGSLEY MD NPI 1053348037

NPI Details

DR. Clint Daniel Kingsley, MD is a hematology and oncology internal medicine in Florence, AL with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Clint Daniel Kingsley, MD NPI is 1053348037. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:2001

The provider's business location address is:

180 COX CREEK PKWY S STE B
FLORENCE, AL
ZIP 35630-263
Phone: (256) 760-0422

The NPI 1053348037 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Iron level (HCPCS:83540)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron binding capacity (HCPCS:83550)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Nephelometry, test method using light (HCPCS:83883)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Phosphate level (HCPCS:84100)
• Folic acid level, serum (HCPCS:82746)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Unclassified drugs (HCPCS:J3490)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Protein measurement, serum (HCPCS:84165)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Automated urinalysis test (HCPCS:81003)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Translocation analysis (bcr/abl1) major breakpoint (HCPCS:81206)
• Translocation analysis (bcr/abl1) minor breakpoint (HCPCS:81207)
• Injection of drug or substance into vein (HCPCS:96374)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Erythropoietin (protein) level (HCPCS:82668)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Beta-2 microglobulin (protein) level (HCPCS:82232)

The enumeration date for this NPI number is 6/27/2006 and was last updated on 1/27/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.